Life Sciences

Clinical research company Veristat will move its headquarters from Holliston to Southborough this summer as it meets higher demand from its pharmaceutical and biotechnology clients, the company said Tuesday

Framingham-based medical device maker Arch Therapeutics has entered into a research collaboration with the CURAM Centre for Research in Medical Devices, based in Ireland, Arch announced Monday.

Framingham-based life sciences company SCIEX has collaborated with a North Carolina company to enhance research into cardiovascular disease, diabetes and neurodegenerative disorders, according to a statement from SCIEX.

RXi Pharmaceuticals of Marlborough said last week it is making a public offering of common stock and warrants.

Marlborough's Ocata Therapeutics has been awarded three new patents connected to its stem-cell transplant technology for treating macular degenerative diseases.

Verax Biomedical, a young medical device company that makes a rapid test that screens for bacterial contamination in blood platelets, announced it has gained federal clearance to expand the use of its product.

A year after the head of the state's biotech funding agency announced she would step down, officials tasked with choosing her successor have hit the reset button on the search.

Pharmaceuticals giant AbbVie, which has operations in Worcester, has completed its purchase of California-based Pharmacyclics Inc., AbbVie announced Tuesday.

Marlborough's growing reputation as a magnet for companies strengthened this month with news that Hologic Inc. wants to move its headquarters 32 miles southwest from Bedford. Read more about the company's plans.

University of Massachusetts Medical School professor Job Dekker has won a coveted scientific honor. He has been named a Howard Hughes Medical Institute (HHMI) Investigator, the medical school's seventh.